TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,952 | -66.3% | 353 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $8,769 | +65.1% | 353 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $5,310 | +27.2% | 353 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,176 | +108.8% | 353 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -57.1% | 353 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 353 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $12,000 | -14.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -17.6% | 353 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $17,000 | +70.0% | 353 | +81.0% | 0.00% | +33.3% |
| Q4 2020 | $10,000 | +100.0% | 195 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $5,000 | +25.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +100.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |